138 related articles for article (PubMed ID: 12215235)
1. Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
Dale LC; Ebbert JO; Schroeder DR; Croghan IT; Rasmussen DF; Trautman JA; Cox LS; Hurt RD
Nicotine Tob Res; 2002 Aug; 4(3):267-74. PubMed ID: 12215235
[TBL] [Abstract][Full Text] [Related]
2. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
3. Nicotine lozenges for the treatment of smokeless tobacco use.
Ebbert JO; Dale LC; Severson H; Croghan IT; Rasmussen DF; Schroeder DR; Vander Weg MW; Hurt RD
Nicotine Tob Res; 2007 Feb; 9(2):233-40. PubMed ID: 17365754
[TBL] [Abstract][Full Text] [Related]
4. Measuring nicotine dependence among smokeless tobacco users.
Thomas JL; Ebbert JO; Patten CA; Dale LC; Bronars CA; Schroeder DR
Addict Behav; 2006 Sep; 31(9):1511-21. PubMed ID: 16386854
[TBL] [Abstract][Full Text] [Related]
5. Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco users.
Ebbert JO; Dale LC; Patten CA; Croghan IT; Schroeder DR; Moyer TP; Hurt RD
Nicotine Tob Res; 2007 Jan; 9(1):43-52. PubMed ID: 17365735
[TBL] [Abstract][Full Text] [Related]
6. Residential treatment for smokeless tobacco use: a case series.
Ebbert JO; Dale LC; Vickers KS; Gauvin TR; Bunge NE; Hurt RD
J Subst Abuse Treat; 2004 Jun; 26(4):261-7. PubMed ID: 15182890
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
Dalsgareth OJ; Hansen NC; Søes-Petersen U; Evald T; Høegholm A; Barber J; Vestbo J
Nicotine Tob Res; 2004 Feb; 6(1):55-61. PubMed ID: 14982688
[TBL] [Abstract][Full Text] [Related]
8. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
9. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
Evins AE; Mays VK; Rigotti NA; Tisdale T; Cather C; Goff DC
Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208
[TBL] [Abstract][Full Text] [Related]
10. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Nides M; Oncken C; Gonzales D; Rennard S; Watsky EJ; Anziano R; Reeves KR
Arch Intern Med; 2006 Aug 14-28; 166(15):1561-8. PubMed ID: 16908788
[TBL] [Abstract][Full Text] [Related]
11. Bupropion SR for the treatment of smokeless tobacco use.
Dale LC; Ebbert JO; Glover ED; Croghan IT; Schroeder DR; Severson HH; Hurt RD
Drug Alcohol Depend; 2007 Sep; 90(1):56-63. PubMed ID: 17353101
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
13. Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results.
Niederhofer H; Huber M
Pharmacotherapy; 2004 Nov; 24(11):1524-8. PubMed ID: 15537557
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
McCarthy DE; Piasecki TM; Lawrence DL; Jorenby DE; Shiffman S; Fiore MC; Baker TB
Nicotine Tob Res; 2008 Apr; 10(4):717-29. PubMed ID: 18418793
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
Killen JD; Robinson TN; Ammerman S; Hayward C; Rogers J; Stone C; Samuels D; Levin SK; Green S; Schatzberg AF
J Consult Clin Psychol; 2004 Aug; 72(4):729-35. PubMed ID: 15301658
[TBL] [Abstract][Full Text] [Related]
16. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
[TBL] [Abstract][Full Text] [Related]
17. No evidence for a major role of polymorphisms during bupropion treatment.
Hu J; Redden DT; Berrettini WH; Shields PG; Restine SL; Pinto A; Lerman C; Allison DB
Obesity (Silver Spring); 2006 Nov; 14(11):1863-7. PubMed ID: 17135598
[TBL] [Abstract][Full Text] [Related]
18. Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.
Jain AK; Kaplan RA; Gadde KM; Wadden TA; Allison DB; Brewer ER; Leadbetter RA; Richard N; Haight B; Jamerson BD; Buaron KS; Metz A
Obes Res; 2002 Oct; 10(10):1049-56. PubMed ID: 12376586
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.
Cox LS; Patten CA; Niaura RS; Decker PA; Rigotti N; Sachs DP; Buist AS; Hurt RD
J Gen Intern Med; 2004 Aug; 19(8):828-34. PubMed ID: 15242467
[TBL] [Abstract][Full Text] [Related]
20. Effect of glucose on tobacco withdrawal symptoms in recent quitters using bupropion or nicotine replacement.
McRobbie H; Hajek P
Hum Psychopharmacol; 2004 Jan; 19(1):57-61. PubMed ID: 14716714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
